TACR2 Antikörper (Intracellular, N-Term)

Produktnummer ABIN7885567

Der Kaninchen Polyklonal anti-TACR2 Antikörper wird verwendet zum Nachweis von TACR2 in Proben von Ratte und Maus. Er wurde validiert für WB und IHC.

Kurzübersicht für TACR2 Antikörper (Intracellular, N-Term) (ABIN7885567)

Target: TACR2 (Tachykinin Receptor 2 (TACR2))

Reaktivität: Ratte, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TACR2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Güteklasse: Carrier-free

Produktdetails anti-TACR2 Antikörper

Bindungsspezifität: AA 351-367, Intracellular, N-Term

Verwendungszweck: A Rabbit Polyclonal Antibody to Neurokinin 2 Receptor

Homologie: Mouse - identical, human - 13,17 amino acid residues identical

Aufreinigung: Affinity purified on immobilized antigen.

Immunogen: CHTKETLFMTGDMTHSE, corresponding to amino acid residues 351-367 of rat NK2 receptor

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

WB: 1:200

FC: The optimal concentration should be determined by the user

ICC: The optimal concentration should be determined by the user

IHC: The optimal concentration should be determined by the user

IP: The optimal concentration should be determined by the user

Kommentare:

Negative Control: (ABIN7237373)

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: 0.2 mL double distilled water (DDW)

Konzentration: 1 mg/mL

Buffer: PBS pH 7.4

Konservierungsmittel: Without preservative

Lagerung: -20 °C

Informationen zur Lagerung: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C

Details zu TACR2

Target: TACR2 (Tachykinin Receptor 2 (TACR2))

Andere Bezeichnung: NK2 receptor

Hintergrund:

Synonyms: NK2 receptor, Neurokinin A receptor, Tachykinin receptor 2, TACR2, Substance-K receptor, SKR

Description: Substance P (SP), Neurokinin A (NKA) and Neurokinin B (NKB) are all peptides belonging to the Tachykinin protein family. These three peptides, which demonstrate quite a heterogeneity in their distribution, exert their effect via three receptors: Neurokinin 1-3 receptors, members of the G-protein coupled receptor superfamily. However, Neurokinin 1 (NK1) receptor preferentially binds Substance P, Neurokinin 2 (NK2) receptor to NKA, and Neurokinin 3 (NK3) receptor to NKB1.Neurokinin receptors are distinguished by their seven transmembrane domains, an extracellular N-terminus and a cytosolic C-terminal. An unusual property of these receptors is the presence of introns as part of their structural organization1-3. Tachykinin receptors undergo alternative splicing. For example, NK1 receptor is detected with different C-terminal lengths. The longer receptor isoform is found in the brain whereas the truncated form is mostly detected in the periphery1,4.Due to the broad expression profile of tachykinin peptides, their respective receptors are also expressed in a similar fashion. NK1 receptor is widely expressed in neurons, endothelial cells, muscle and immune system cells. NK2 receptor is broadly expressed in the periphery and its expression in the brain is quite restricted. NK3 receptor on the other hand is largely expressed in the central nervous system and is also detected in the uterus, skeletal muscle, lung and liver1.Neurokinin receptors have been found in many pathophysiological indications and have therefore become targets for the development of pharmacological compounds. Such indications include cancer, psychological disorders, migraine and various inflammations, just to name a few5-8.

Gen-ID: 25007

UniProt: P16610

Pathways: Hormone Transport, Negative Regulation of Hormone Secretion